On August 18th, the Executive Committee in special action bestowed on Norm Goodman the Ram Chugh Senate Outstanding Service Award.

As described in the text of the resolution, this award to Norm is well deserved and long overdue, given his long service to the Senate: his advocacy for restoring the role of faculty determining the curriculum, following unilateral implementation of a general education framework by the Board of Trustees in the late 1990s; his long leadership of the Undergraduate Committee; his work in publishing the Bulletin; his stint as Vice President / Secretary; among other aspects of his service.  Norm was also the inaugural recipient of the Carl P. Wiezalis University Faculty Senate Fellow Award.

Norm was already a long-established leader of the Senate when I joined nearly a decade ago as freshman Senator from Purchase College.  I will always appreciate Norm welcoming me as a new member of the Senate; his tenacity in debating the issues that came before the body; and his ability to provide much needed perspective on the history of the Senate.  I am glad that one of my first actions as President of the UFS was to shepherd this award for Norm through the Executive Committee.

Norm's contributions to Stony Brook (and to the UFS) were recognized in a virtual celebration (Norman Goodman: 56 years a Seawolf) organized by his colleagues in the University Senate and Sociology Department there.  And in the story in Stony Brook News (University Senate, Department of Sociology Celebrating Norman Goodman’s 56 Years as a Seawolf).  Although as Norm was quick to point out, that should be 57 years as a Seawolf.

​Norm - you leave behind huge shoes to fill....

The following documents have been distributed to campus Presidents and CAOs, from the office of the Chancellor:

• COVID-19 Vaccination policy 
• FAQs on the policy 
• Guidance on exemptions 
• Templates for exemptions: Medical; Religious  
• Guidance on the NYS Public Health Law Section 16 Order mandating vaccines for hospitals and other health care facilities 

In addition to these documents, the Chancellor shared the following press release from the FDA on its final approval for the ​Pfizer-BioNTech COVID-19 Vaccine: